| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
1 | AN ACT concerning health.
| ||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||
4 | Section 1. Short title. This Act may be cited as the | ||||||||||||||||||||||||
5 | Administration of Antibiotics to Food-Producing Animals Act.
| ||||||||||||||||||||||||
6 | Section 5. Findings; purpose. | ||||||||||||||||||||||||
7 | (a) The General Assembly finds and declares that: | ||||||||||||||||||||||||
8 | (1) the World Health Organization has stated that | ||||||||||||||||||||||||
9 | "without urgent, coordinated action by many stakeholders, | ||||||||||||||||||||||||
10 | the world is headed for a post-antibiotic era, in which | ||||||||||||||||||||||||
11 | common infections and minor injuries which have been | ||||||||||||||||||||||||
12 | treatable for decades can once again kill"; | ||||||||||||||||||||||||
13 | (2) the United States Food and Drug Administration and | ||||||||||||||||||||||||
14 | the Centers for Disease Control and Prevention have stated | ||||||||||||||||||||||||
15 | that there is a definitive link between the routine use of | ||||||||||||||||||||||||
16 | antibiotics on industrial farms and the crisis of | ||||||||||||||||||||||||
17 | antibiotic resistance in humans; | ||||||||||||||||||||||||
18 | (3) the issue of antibiotics overuse, whether on humans | ||||||||||||||||||||||||
19 | or animals, is a significant and urgent human health | ||||||||||||||||||||||||
20 | matter; | ||||||||||||||||||||||||
21 | (4) the World Health Organization recommends "complete | ||||||||||||||||||||||||
22 | restriction of use of all classes of medically important | ||||||||||||||||||||||||
23 | antimicrobials in food-producing animals for prevention of |
| |||||||
| |||||||
1 | infectious diseases that have not yet been clinically | ||||||
2 | diagnosed"; | ||||||
3 | (5) approximately 70% of medically important | ||||||
4 | antibiotics sold in the United States are given to | ||||||
5 | food-producing animals, often in a routine manner for | ||||||
6 | promoting growth or to compensate for the effects of | ||||||
7 | unsanitary and overcrowded living conditions;
| ||||||
8 | (6) many of the antibiotics provided to food-producing | ||||||
9 | animals are identical to, or from the same family as, drugs | ||||||
10 | used in human medicine to cure serious diseases; therefore, | ||||||
11 | bacterial resistance to these drugs poses a threat to human | ||||||
12 | health because these drugs may not work to treat human | ||||||
13 | disease when needed; and | ||||||
14 | (7) passing this Act is necessary to protect the health | ||||||
15 | and safety of Illinois consumers from antibiotic resistant | ||||||
16 | bacteria spreading through the food supply.
| ||||||
17 | (b) The purpose of this Act is to protect public health by | ||||||
18 | preserving the effectiveness of antibiotics now and for future | ||||||
19 | generations by eliminating the routine use of those important | ||||||
20 | medicines in food-producing animals for growth promotion, feed | ||||||
21 | efficiency, and prophylaxis, in order to reduce the rise and | ||||||
22 | spread of antibiotic resistant bacteria.
| ||||||
23 | Section 10. Definitions. As used in this Act: | ||||||
24 | "Control the spread of a disease or infection" means the | ||||||
25 | use of a medically important antibiotic to stop the |
| |||||||
| |||||||
1 | transmission of a documented disease or infection present in: | ||||||
2 | (1) a group of animals in contact with each other; or | ||||||
3 | (2) a barn or equivalent animal housing unit.
| ||||||
4 | "Department" means the Department of Public Health. | ||||||
5 | "Food-producing animal" means: | ||||||
6 | (1) cattle, swine, or poultry, regardless of whether | ||||||
7 | the specific animal is raised for the purpose of producing | ||||||
8 | food for human consumption; or | ||||||
9 | (2) any type of animal that the Department identifies | ||||||
10 | by rule as livestock typically used to produce food for | ||||||
11 | human consumption.
| ||||||
12 | "Producer" means a person or entity that establishes | ||||||
13 | management and production standards for the maintenance, care, | ||||||
14 | and raising of food-producing animals and that: | ||||||
15 | (1) operates a business raising food-producing animals | ||||||
16 | that are used to produce any product group sold by a | ||||||
17 | grocer; or | ||||||
18 | (2) purchases or otherwise obtains live food-producing | ||||||
19 | animals that it slaughters, or sells for slaughter, for | ||||||
20 | production of any product group sold by a grocer.
| ||||||
21 | "Medically important antibiotic" means a drug that is | ||||||
22 | composed in whole or in part of a drug from an antimicrobial | ||||||
23 | class that is categorized as critically important, highly | ||||||
24 | important, or important in the World Health Organization list | ||||||
25 | of Critically Important Antimicrobials for Human Medicine (5th | ||||||
26 | Revision, 2017), or a subsequent revision or successor document |
| |||||||
| |||||||
1 | issued by the World Health Organization. | ||||||
2 | "Prophylaxis" means the administration of a medically | ||||||
3 | important antibiotic to an animal or multiple animals in the | ||||||
4 | absence of contact with animals with a clinically diagnosed | ||||||
5 | disease for the purpose of avoiding illness. | ||||||
6 | "Treat a disease" means administering a medically | ||||||
7 | important antibiotic to infected individual animals or | ||||||
8 | populations of animals to resolve clinical signs of infection | ||||||
9 | or illness.
| ||||||
10 | Section 15. Administration of antibiotics to | ||||||
11 | food-producing animals. | ||||||
12 | (a) This Section applies to the provision of medically | ||||||
13 | important antibiotics to food-producing animals on or after | ||||||
14 | January 1, 2020. | ||||||
15 | (b) A medically important antibiotic may be administered to | ||||||
16 | a food-producing animal only if prescribed by a veterinarian | ||||||
17 | licensed under the Veterinary Medicine and Surgery Practice Act | ||||||
18 | of 2004 who has visited the farm operation within the previous | ||||||
19 | 6 months and only if deemed necessary: | ||||||
20 | (1) to treat a disease; | ||||||
21 | (2) to control the spread of a disease or infection; or | ||||||
22 | (3) in relation to a surgical or other medical | ||||||
23 | procedure that exposes normally sterile body sites to | ||||||
24 | infection. | ||||||
25 | (c) A producer may provide a medically important antibiotic |
| |||||||
| |||||||
1 | to a food-producing animal only for the period necessary to | ||||||
2 | accomplish a purpose described in subsection (b). In that case, | ||||||
3 | antibiotics should be used on the smallest number of animals | ||||||
4 | and for the shortest time possible. The use of medically | ||||||
5 | important antibiotics shall not exceed a duration of 21 days. | ||||||
6 | In addition to any information described in Section 20, the | ||||||
7 | producer shall keep a record of the specific beginning and | ||||||
8 | ending dates for the provision of an antibiotic. | ||||||
9 | (d) A medically important antibiotic may not be | ||||||
10 | administered to food-producing animals solely for the purpose | ||||||
11 | of:
| ||||||
12 | (1) promoting weight gain; | ||||||
13 | (2) improving feed efficiency; or | ||||||
14 | (3) prophylaxis.
| ||||||
15 | Section 20. Annual report. | ||||||
16 | (a) A producer that operates a large concentrated animal | ||||||
17 | feeding operation, as defined by the United States | ||||||
18 | Environmental Protection Agency, must file an annual report | ||||||
19 | under this Section in a form and manner required by the | ||||||
20 | Department by rule. If the producer and a contracting entity | ||||||
21 | enter into an agreement for the contracting entity to assume | ||||||
22 | the annual report filing duty, the contracting entity shall | ||||||
23 | include in the annual report the name and address of the | ||||||
24 | producer on whose behalf the contracting entity is submitting | ||||||
25 | the annual report. If any medically important antibiotics were |
| |||||||
| |||||||
1 | provided to food-producing animals during the reporting | ||||||
2 | period, then the annual report must contain the following | ||||||
3 | information: | ||||||
4 | (1) the location of the facility where the | ||||||
5 | antimicrobial was used; | ||||||
6 | (2) the antimicrobial and class of antimicrobial used; | ||||||
7 | (3) the duration of use, including the number of | ||||||
8 | treatment days; | ||||||
9 | (4) the species and production class of animals | ||||||
10 | receiving the antimicrobial; | ||||||
11 | (5) the number of animals receiving the antimicrobial; | ||||||
12 | (6) the total number of animals raised at the facility, | ||||||
13 | this data is key to understanding variations in use and | ||||||
14 | benchmarking performance; | ||||||
15 | (7) the indication and purpose for which the | ||||||
16 | veterinarian prescribed the antimicrobial; | ||||||
17 | (8) the dosage of the antimicrobial; and | ||||||
18 | (9) any other information required to be kept pursuant | ||||||
19 | to U.S. Food and Drug Administration regulations 21 CFR | ||||||
20 | 558.6(b)(3) and 21 CFR 558.6(b)(4).
| ||||||
21 | (b) Information provided under paragraph (7) of subsection | ||||||
22 | (a) must include whether a medically-important antibiotic was | ||||||
23 | provided to a food-producing animal for the purpose of: | ||||||
24 | (1) surgery or a medical procedure; | ||||||
25 | (2) disease control; or | ||||||
26 | (3) disease treatment. |
| |||||||
| |||||||
1 | (c) Information reported under this Section is a public | ||||||
2 | record and is not subject to exemption from disclosure. The | ||||||
3 | Department may not redact, withhold, or delay the release of | ||||||
4 | information reported under this Section. | ||||||
5 | (d) The Department of Public Health shall consult with the | ||||||
6 | Department of Agriculture as necessary to fulfill the | ||||||
7 | requirements of this Section.
| ||||||
8 | Section 25. Implementation. The Department may take the | ||||||
9 | actions necessary to prepare to implement the provisions of | ||||||
10 | this Act in advance of the effective date of the other | ||||||
11 | provisions of this Act.
| ||||||
12 | Section 30. Violations. The Attorney General has exclusive | ||||||
13 | authority to enforce the provisions of this Act. Each violation | ||||||
14 | of this Act is punishable by a civil penalty not to exceed | ||||||
15 | $1,000. The Attorney General may also seek injunctive relief to | ||||||
16 | prevent further violations of this Act.
|